Educational use only. Check doses against the product monograph and local protocols.

magnesium sulfate

in review 2 min read Updated 2026-10-30
eclampsia / preeclampsia
4 g IV over 20 min → 1 g/h
until 24 h after last seizure or birth
recurrent seizure
2 g IV
over 5–10 min
magnesium sulfate

First-line for treatment and prevention of eclamptic seizures. Not an antihypertensive. Renally cleared — toxicity is monitored clinically (reflexes, RR, urine output), with calcium gluconate as antidote.

mechanism

NMDA antagonism + cerebral vasodilation (relieves vasospasm); calcium-channel blockade at the neuromuscular junction (→ toxicity profile).


dosing

indicationregimen
eclampsia / preeclampsia prophylaxis4 g IV in 100 mL NS over 20 min → 1 g/h, until 24 h after last seizure or birth (whichever later)
IM (no IV, or transport)4 g IV (if possible) + 5 g IM each buttock (10 g; can add 2 mL 1% lidocaine) → 5 g IM one buttock q4h
IM → IV switchstart 1 g/h (no load) when next IM dose due
recurrent seizure on infusionadditional 2 g IV over 5–10 min
AKI / oliguriafull loading dose; reduce or hold maintenance; check level
severe acute asthma (non-obstetric dose)2 g IV over 20 min, single dose
  • ACOG range 1–2 g/h maintenance; SOGC uses 1 g/h
  • SOGC indications: treatment of eclampsia; prophylaxis in preeclampsia with severe HTN or any adverse condition; foetal neuroprotection if delivery imminent <33⁺⁶ wk

key points

  • Severe BP and seizure risk need separate treatment — normalised BP doesn’t remove the Mg indication
  • Phenytoin, benzodiazepines inferior for eclampsia
  • SOGC monitoring: reflexes after load and hourly; BP, HR, RR, SpO₂ q30 min; urine output hourly (Foley)
  • Toxicity triggers: absent reflexes, RR <12 for 15 min, SpO₂ <94% for 15 min, urine <30 mL/h for 4 h, drowsiness/slurred speech
  • Levels only if ↓ renal function or suspected toxicity
  • Nifedipine + Mg can be given together (SOGC) — no ↑ serious Mg-related adverse effects
  • Prolongs neuromuscular blockade — tell anaesthesia
toxicity — act on clinical signs, not the level

Loss of reflexes → somnolence, slurred speech → respiratory depression → cardiac arrest. Stop infusion, send Mg level → calcium gluconate 10% 10 mL (1 g) IV over 3 min → support ventilation; dialysis if renal failure.

serum Mg (mmol/L)effect
2.0–3.5therapeutic
>3.5–5loss of patellar reflexes
>5–6.5respiratory depression
>7.5cardiac conduction defects, arrest

adverse effects

  • Flushing, warmth, nausea, muscle weakness (expected)
  • Hypotension (mild), pulmonary oedema with fluid overload
  • Neonatal hypotonia/respiratory depression with prolonged use

evidence

  • Magpie (2002) — n≈10,000 with preeclampsia; eclampsia 0.8% vs 1.9% (RRR 58%); trend to lower maternal mortality; no foetal harm

Prepared 2026-10-30. Not yet verified — check every number against the sources.

Key references

Suggest a correction magnesium sulfate